Clinical And Morphological Improvement Of Lupus Nephritis Treated With Rituximab

Clinical And Morphological Improvement Of Lupus Nephritis Treated With Rituximab

Aim: TO assess the effects of rituximab (RTM) therapy on clinical and morphologic activity of lupus nephritis (LN).

Bibliographic Details
Main Authors:	Tsanyan Maria E., Soloviev Sergey K., Radenska-Lopovok Stefka G., Torgashina Anna V., Nikolaeva Ekaterina V., Khrennikov Yaroslav B., Nasonov Evgeniy L.
Format:	Article
Language:	English
Published:	Pensoft Publishers 2014-12-01
Series:	Folia Medica
Subjects:	systemic lupus erythematosus lupus nephritis rituximab morphology of lupus nephritis renal biopsy системная красная волчанка волчаночный нефрит ритуксимаб морфология волчаночного нефрита биопсия почки
Online Access:	http://www.degruyter.com/view/j/folmed.2014.56.issue-4/folmed-2015-0003/folmed-2015-0003.xml?format=INT

Similar Items

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I
by: N. L. Kozlovskaya, et al.
Published: (2020-11-01)

Programmed immunoadsorption with regeneration of adsoption columns in the treatment of lupus nephritis
by: A. A. Sokolov, et al.
Published: (2020-09-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Experience in Rituximab Administration in Children with Systemic Lupus Erythematosus: a Retrospective Study of the Case Series
by: Mikhail M. Kostik, et al.
Published: (2016-08-01)

Lupus nephritis : frontiers and challenges /
by: Sheashaa, Hussein A.
Published: (2010)

Anti-B cell therapy in patients with systemic lupus erythematosus
by: M. E. Tsanyan, et al.
Published: (2018-01-01)

Lupus Nephritis in Pediatric Practice: 20-Year Experience in Care
by: G. A. Makovetskaya, et al.
Published: (2021-01-01)

Characteristics of systemic lupus erythematosus and lupus nephritis in children in the Republic of Belarus and the Republic of Tatarstan
by: T. P. Makarova, et al.
Published: (2019-11-01)

Tubulointerstitial lupus nephritis
by: Ala Ali, et al.
Published: (2013-01-01)

General principles in the treatment of lupus nephritis with the prevention of cardiovascular events
by: Т. A. Panafidina, et al.
Published: (2018-12-01)

Effect of biological agents on B-lymphocyte subpopulations in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2019-03-01)

EFFICACY AND SAFETY OF RITUXIMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A RETROSPECTIVE STUDY OF THE CASE SERIES
by: Ekaterina I. Alexeeva, et al.
Published: (2016-11-01)

Lupus Nephritis, the therapy and the role of Rituximab in resistant cases
by: Hussein A. Nasir, et al.
Published: (2014-01-01)

Lupus Nephritis in Males: Clinical Features, Course, and Prognostic Factors for End-Stage Renal Disease
by: Andrés Urrestarazú, et al.
Published: (2017-09-01)

Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis
by: Muhammed Mubarak
Published: (2013-01-01)

ANTI-CD20 MONOCLONAL ANTIBODIES IN TREATMENT OF HAEMOLYTIC ANEMIA IN A TEENAGE GIRL WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: R. V. Denisova, et al.
Published: (2012-11-01)

Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01)

Clinicopathological, Immunological, and Laboratory Parameters of Childhood Lupus Nephritis: A Study from Northeast India
by: Jonali Das, et al.
Published: (2023-09-01)

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part II
by: N. L. Kozlovskaya, et al.
Published: (2021-02-01)

The Clinicopathological Study of Lupus Nephritis
by: Raouf Rahim Merza, et al.
Published: (2014-08-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case
by: D. Jain, et al.
Published: (2014-03-01)

Current and Emerging Therapy on Lupus Nephritis
by: Lucky Aziza Bawazier
Published: (2018-01-01)

Experience using low doses of calcineurin inhibitors in the treatment of refractory lupus nephritis
by: César Augusto Restrepo Valencia, et al.
Published: (2014-10-01)

Lupus Nephritis Biomarkers: A Critical Review
by: Fatima K. Alduraibi, et al.
Published: (2024-01-01)

Skin lesions in systemic lupus erythematosus. Part 2: clinical and histological features
by: A. A. Shumilova, et al.
Published: (2022-08-01)

Lupus Nephritis and Dysbiosis
by: Marta Monticolo, et al.
Published: (2023-04-01)

Immunophenotyping identifies distinct cellular signatures for systemic lupus erythematosus and lupus nephritis
by: Yi Tong V. Aw, et al.
Published: (2023-03-01)

Exploratory study of serum IL-36 subfamily as biomarkers of disease progression in lupus nephritis
by: Chao Liu, et al.
Published: (2023-10-01)

A study on the relationship between morphological lesions of lupus nephritis with demographic and biochemical findings
by: Nasrin Tavassoli, et al.
Published: (2022-01-01)

Biomarkers in biological fluids and their potential use as indicators of lupus nephritis in individuals with systemic lupus erythematous
by: Lisandro Pacheco-Lugo, et al.
Published: (2014-05-01)

Prognostic Factors In Children With Lupus Nephritis
by: Ataei N, et al.
Published: (2005-06-01)

Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis
by: Martina Bertolo, et al.
Published: (2020-03-01)

Treatment of patients with systemic lupus erythematosus without glucocorticoids – myth or reality?
by: S. K. Soloviev, et al.
Published: (2022-02-01)

Association of anti C1q and ds-DNA levels with the pathogenesis of Lupus Nephritis among SLE patients
by: Zara Sohail, et al.
Published: (2018-02-01)

Management of refractory lupus nephritis: challenges and solutions
by: Yo JH, et al.
Published: (2019-07-01)

CYTOKINE PROFILE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Maria Eduardovna Tsanyan, et al.
Published: (2013-12-01)

Renalase and lupus nephritis: disease activity and histopathological classification
by: Marwa Y Mahgoub, et al.
Published: (2018-01-01)